Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00282620|
Recruitment Status : Unknown
Verified March 2007 by Hartford Hospital.
Recruitment status was: Recruiting
First Posted : January 27, 2006
Last Update Posted : November 20, 2007
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Primary Completion Date :||No date given|
|Estimated Study Completion Date :||June 2008|